Table 2 Univariate and multivariate Cox regression analysis for CRC-specific survival
CRC-specific survival | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
Variable | HR | 95% CI | P value | HR | 95% CI | p value |
Age (≧65 vs <65) | 3.317 | 1.374–8.003 | 0.008 | 4.330 | 1.454–12.899 | 0.008 |
Gender (male vs female) | 0.884 | 0.397–1.968 | 0.763 | 1.680 | 0.615–4.587 | 0.311 |
Stage (late vs early) | 1.447 | 0.648–3.231 | 0.368 | 0.991 | 0.323–3.045 | 0.988 |
Differentiation (Poorly vs others) | 4.485 | 1.859–10.823 | 0.001 | 5.704 | 1.737–18.733 | 0.004 |
Location (left vs right) | 0.831 | 0.372–1.857 | 0.651 | 1.682 | 0.610–4.637 | 0.315 |
CEA (>5 vs ≦5) | 4.364 | 1.808–10.534 | 0.001 | 2.764 | 0.866–8.824 | 0.086 |
CA19-9 (>37 vs ≦37) | 4.626 | 2.022–10.585 | <0.001 | 4.109 | 1.248–13.534 | 0.020 |
MSI (MSS vs MSI) | 0.630 | 0.184–2.153 | 0.461 | 0.276 | 0.063–1.200 | 0.086 |
Round cell infiltration (positive vs negative) | 1.019 | 0.446–2.330 | 0.964 | 1.043 | 0.379–2.867 | 0.935 |
Lymphatic invasion (positive vs negative) | 3.402 | 1.523–7.599 | 0.003 | 1.328 | 0.452–3.904 | 0.606 |
SIGLEC14 (positive vs negative) | 0.707 | 0.317–1.577 | 0.397 | 1.005 | 0.389–2.596 | 0.992 |
LGALS3BP (high vs low) | 2.484 | 1.085–5.685 | 0.031 | 5.948 | 1.899–18.630 | 0.002 |